Literature DB >> 26375521

Cepharanthine mitigates pro-inflammatory cytokine response in lung injury induced by hemorrhagic shock/resuscitation in rats.

Ming-Chang Kao1, Chen-Hsien Yang2, Joen-Rong Sheu3, Chun-Jen Huang4.   

Abstract

BACKGROUND: Cepharanthine possesses strong anti-inflammation capacity. We sought to clarify whether cepharanthine could mitigate pro-inflammatory cytokine production in acute lung injury induced by hemorrhagic shock/resuscitation (HS/RES). The involvement of heme oxygenase-1 (HO-1) was also investigated.
METHODS: Male Sprague Dawley rats were allocated to receive HS/RES, HS/RES plus iv cepharanthine or HS/RES plus cepharanthine plus the HO-1 activity inhibitor tin protoporphyrin (SnPP) and denoted as the HS/RES, HS/RES+CEP, and HS/RES+CEP+SnPP group, respectively. HS/RES was achieved by blood drawing to lower mean arterial pressure (40-45 mmHg for 60 min) followed by shed blood/saline mixtures re-infusion. The rats were monitored for another 5h before sacrifice.
RESULTS: Arterial blood gas, lung permeability and histologic assays (including histopathology, neutrophil infiltration, and lung water content) confirmed that HS/RES induced significant lung injury. Significant increases in pulmonary levels of tumor necrosis factor-α, interleukin-1β, interleukin-6, prostaglandin E2 and cyclooxygenase-2 confirmed that HS/RES induced a significant inflammatory response in the lungs. Cepharanthine significantly attenuated the pulmonary pro-inflammatory cytokine production and lung injury induced by HS/RES. However, the protective effects of cepharanthine were blocked by SnPP, the potent HO-1 activity inhibitor.
CONCLUSION: Cepharanthine significantly mitigates pro-inflammatory cytokine response in acute lung injury induced by HS/RES in rats. The mechanism may involve the HO-1 pathway.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-inflammatory; Heme oxygenase-1; Interleukin; Tin protoporphyrin; Tumor necrosis factor-α

Mesh:

Substances:

Year:  2015        PMID: 26375521     DOI: 10.1016/j.cyto.2015.09.008

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  10 in total

1.  Protective effect of bone marrow derived mesenchymal stem cells in lipopolysaccharide-induced acute lung injury mediated by claudin-4 in a rat model.

Authors:  Yueliang Zheng; Wenwei Cai; Shengang Zhou; Liming Xu; Chengxing Jiang
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

2.  Dimethyl Sulfoxide Attenuates Acute Lung Injury Induced by Hemorrhagic Shock/Resuscitation in Rats.

Authors:  Yu-Chi Tsung; Chih-Yang Chung; Hung-Chieh Wan; Ya-Ying Chang; Ping-Cheng Shih; Han-Shui Hsu; Ming-Chang Kao; Chun-Jen Huang
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

3.  Protective effects of hesperetin on lipopolysaccharide-induced acute lung injury in a rat model.

Authors:  Serkan Kaya; Sinem Albayrak Kaya; Elif Polat; Zeynep Fidanol Erboğa; Yasin Duran; Fatin Rüştü Polat; Hamza Malik Okuyan; İhsan Karaboğa
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2020-04-22       Impact factor: 0.332

4.  Inhibition of BTK protects lungs from trauma-hemorrhagic shock-induced injury in rats.

Authors:  Xinwei Liu; Jingdong Zhang; Wenfeng Han; Yu Wang; Yunen Liu; Yubiao Zhang; Dapeng Zhou; Liangbi Xiang
Journal:  Mol Med Rep       Date:  2017-05-09       Impact factor: 2.952

Review 5.  Cepharanthine: An update of its mode of action, pharmacological properties and medical applications.

Authors:  Christian Bailly
Journal:  Phytomedicine       Date:  2019-05-10       Impact factor: 5.340

6.  Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment.

Authors:  Hirofumi Ohashi; Koichi Watashi; Wakana Saso; Kaho Shionoya; Shoya Iwanami; Takatsugu Hirokawa; Tsuyoshi Shirai; Shigehiko Kanaya; Yusuke Ito; Kwang Su Kim; Takao Nomura; Tateki Suzuki; Kazane Nishioka; Shuji Ando; Keisuke Ejima; Yoshiki Koizumi; Tomohiro Tanaka; Shin Aoki; Kouji Kuramochi; Tadaki Suzuki; Takao Hashiguchi; Katsumi Maenaka; Tetsuro Matano; Masamichi Muramatsu; Masayuki Saijo; Kazuyuki Aihara; Shingo Iwami; Makoto Takeda; Jane A McKeating; Takaji Wakita
Journal:  iScience       Date:  2021-03-26

7.  Cepharanthine loaded nanoparticles coated with macrophage membranes for lung inflammation therapy.

Authors:  Caihong Lu; Jinpeng Zheng; Yaning Ding; Yuanyuan Meng; Fangyun Tan; Wei Gong; Xiaoyang Chu; Xiaolong Kong; Chunsheng Gao
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

8.  Cepharanthine ameliorates dextran sulphate sodium-induced colitis through modulating gut microbiota.

Authors:  Hong-Gang Wang; Min-Na Zhang; Xin Wen; Le He; Meng-Hui Zhang; Jia-Ling Zhang; Xiao-Zhong Yang
Journal:  Microb Biotechnol       Date:  2022-04-19       Impact factor: 6.575

9.  Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals.

Authors:  Pengjun Zhou; Rong Zhang; Ying Wang; Dandan Xu; Li Zhang; Jinhong Qin; Guifeng Su; Yue Feng; Hongce Chen; Siyuan You; Wen Rui; Huizhong Liu; Suhong Chen; Hongyuan Chen; Yifei Wang
Journal:  Oncotarget       Date:  2017-11-27

10.  Tumor Necrosis Factor-α Mediates Lung Injury in the Early Phase of Endotoxemia.

Authors:  Kung-Yen Chen; Chao-Yuan Chang; Hao-Jen Hsu; Hung-Jen Shih; I-Tao Huang; Hemal H Patel; Chun-Jen Huang
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.